The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam

Background: Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Huyen Anh, Cooke, Graham S., Day, Jeremy N., Flower, Barnaby, Phuong, Le Thanh, Hung, Trinh Manh, Dung, Nguyen Thanh, Khoa, Dao Bach, Hung, Le Manh, Kestelyn, Evelyne, Thwaites, Guy E., Chau, Nguyen Van Vinh, Turner, Hugo C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372532/
https://www.ncbi.nlm.nih.gov/pubmed/32734002
http://dx.doi.org/10.12688/wellcomeopenres.15408.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372532/
https://www.ncbi.nlm.nih.gov/pubmed/32734002
http://dx.doi.org/10.12688/wellcomeopenres.15408.2

Ejemplares similares